Clinical Trial Update: Midterm (Min. 3yr) Follow-up of Patients With Single Spiral/Oblique Finger Metacarpal Fracture [NA]

View source ↗

Summary

The trial has completed midterm follow-up (minimum 3 years) in patients with a single spiral or oblique finger metacarpal fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metacarpal Fracture

Snippet

Sponsor: Uppsala University | Conditions: Metacarpal Fracture | NA | Status: COMPLETED